You are here

Elanco acquires dairy supplement from Monsanto

Elanco, a division of Eli Lilly and Company, today announced that Lilly has signed an agreement to acquire the worldwide rights to the dairy cow supplement, Posilac (sometribove), as well as the product's supporting operations, from Monsanto Company.

Elanco has exclusively sold sometribove outside of the United States for a decade. Posilac has been safely used for more than 14 years.

Under the terms of the agreement, Lilly will acquire all rights to the Posilac brand, as well as the product's U.S. sales force and its manufacturing facility in Augusta, Georgia.

In return, Monsanto will receive a $300 million upfront payment, as well as contingent consideration. The Posilac dairy business manufacturing and sales teams will be integrated into the Elanco business.

Elanco, a division of Eli Lilly and Company, today announced that Lilly has signed an agreement to acquire the worldwide rights to the dairy cow supplement, Posilac (sometribove), as well as the product's supporting operations, from Monsanto Company.

Read more about

Talk in Marketing

Most Recent Poll

How’s the crop weather at your place?